4536675
Last Update Posted: 2021-04-02
Recruiting status is unknown
All Genders accepted | 40 Years + |
204 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery
This is a double-blind randomized controlled trial evaluating the effect of perioperative dual bronchodilator therapy on post-operative pulmonary function and health-related quality of life (QoL) in mild-to-moderate less symptomatic COPD patients undergoing lung cancer surgery.
Investigators hypothesized that dual bronchodilator, as compared with placebo, would prevent reduction of pulmonary function after surgical resection and improve postoperative health related QoL.
Eligibility
Relevant conditions:
Chronic Obstructive Pulmonary Disease
Non Small Cell Lung Cancer
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
Data sourced from ClinicalTrials.gov